You just read:

Dermata Therapeutics, LLC Announces Positive Top-line Results from their Phase 1 Pharmacokinetic Study of DMT210 in Acne Rosacea Patients

News provided by

Dermata Therapeutics, LLC

28 Sep, 2016, 08:00 ET